
Liquid Dietary Supplements Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Liquid Dietary Supplements Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global liquid dietary supplements market size reached US$ 25.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 40.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2022-2028.
Liquid dietary supplements are consumed to increase the nutritional intake, reduce the risk of chronic diseases, promote long-term health and improve the overall quality of life. These supplements are generally available at fitness centers and drug stores, grocery stores, and health food stores in different forms, including soft gels, capsules, tablets, liquid, powders, and gummies. At present, their demand is escalating across the globe on account of the rising consumer inclination towards functional consumables, which are manufactured using natural ingredients.
Liquid Dietary Supplements Market Trends:
The growing prevalence of undernutrition, especially in children and the geriatric population, represents one of the major factors influencing the market growth. Special liquid dietary supplements with extra calories or protein are widely available to satisfy the specific nutritional needs of individuals. Apart from this, several manufacturers are offering liquid dietary supplements for patients receiving dialysis treatments to expand their product portfolio and existing consumer base. Moreover, they are offering products for tube feeding via online distribution channels, which is contributing to market growth. Liquid dietary supplements are also gaining traction as a convenient alternative to solid dosage forms, such as tablets and capsules, for children or individuals with sensitive or irritable digestive systems. These supplements have a pleasant taste and can be added to drinks and food products like juices and cereals. Furthermore, the increasing number of chronic illnesses and the growing health consciousness among individuals are other factors anticipated to bolster the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global liquid dietary supplements market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on ingredient, application and distribution channel.
Breakup by Ingredient:
Vitamins and Minerals
Botanical
Proteins and Amino Acids
Others
Breakup by Application:
Bone and Joint Health
Heart Health
Immune Health
Sports Nutrition
Weight Loss
Digestive Health
Others
Breakup by Distribution Channel:
Supermarkets and Hypermarkets
Health and Beauty Retail Stores
Drug Stores
Online Stores
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Amway (Alticor Global Holdings Inc), Arkopharma, BASF SE, Bayer AG, DuPont de Nemours Inc., Glanbia plc, GlaxoSmithKline plc and Koninklijke DSM.
Key Questions Answered in This Report
1. What was the size of the global liquid dietary supplements market in 2022?
2. What is the expected growth rate of the global liquid dietary supplements market during 2023-2028?
3. What has been the impact of COVID-19 on the global liquid dietary supplements market?
4. What are the key factors driving the global liquid dietary supplements market?
5. What is the breakup of the global liquid dietary supplements market based on the ingredient?
6. What is the breakup of the global liquid dietary supplements market based on the application?
7. What is the breakup of the global liquid dietary supplements market based on the distribution channel?
8. What are the key regions in the global liquid dietary supplements market?
9. Who are the key players/companies in the global liquid dietary supplements market?
Table of Contents
145 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Liquid Dietary Supplements Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Ingredient
- 6.1 Vitamins and Minerals
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Botanical
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Proteins and Amino Acids
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Others
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 7 Market Breakup by Application
- 7.1 Bone and Joint Health
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Heart Health
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Immune Health
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Sports Nutrition
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Weight Loss
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Digestive Health
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
- 7.7 Others
- 7.7.1 Market Trends
- 7.7.2 Market Forecast
- 8 Market Breakup by Distribution Channel
- 8.1 Supermarkets and Hypermarkets
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Health and Beauty Retail Stores
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Drug Stores
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Online Stores
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
- 10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
- 11 Value Chain Analysis
- 12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
- 13 Price Analysis
- 14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Amway (Alticor Global Holdings Inc)
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 Arkopharma
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.4 BASF SE
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Bayer AG
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 DuPont de Nemours Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Glanbia plc
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.8 GlaxoSmithKline plc
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 Koninklijke DSM
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.